Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
$0.69
+0.3%		$0.62
$0.36
▼
$2.58
$15.32M-0.1525.40 million shs635,890 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.86
+3.9%		$1.02
$0.80
▼
$1.65
$14.35M0.6650,010 shs19,619 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.15
+4.5%		$0.16
$0.03
▼
$1.00
$16.71M1.2674,785 shs65,168 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$6.32
-8.7%		$7.11
$5.02
▼
$95.60
$4.99M0.2344,799 shs15,296 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
+0.32%+1.27%+25.63%-19.55%-45.50%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+3.87%+3.07%-18.48%-15.25%-27.46%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
+4.45%-2.34%-2.30%-27.09%-60.22%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-8.67%+17.91%+12.66%-36.53%-87.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
$0.69
+0.3%		$0.62
$0.36
▼
$2.58
$15.32M-0.1525.40 million shs635,890 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$0.86
+3.9%		$1.02
$0.80
▼
$1.65
$14.35M0.6650,010 shs19,619 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.15
+4.5%		$0.16
$0.03
▼
$1.00
$16.71M1.2674,785 shs65,168 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$6.32
-8.7%		$7.11
$5.02
▼
$95.60
$4.99M0.2344,799 shs15,296 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
+0.32%+1.27%+25.63%-19.55%-45.50%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+3.87%+3.07%-18.48%-15.25%-27.46%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
+4.45%-2.34%-2.30%-27.09%-60.22%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-8.67%+17.91%+12.66%-36.53%-87.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
2.25
Hold$3.50405.63% Upside
IRIDEX Corporation stock logo
IRIX
IRIDEX
2.00
Hold$3.00250.47% Upside
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
2.33
Hold$200.003,064.56% Upside

Current Analyst Ratings Breakdown

Latest XAIR, ADGM, TMDIF, and IRIX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/5/2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/21/2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/20/2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/17/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/1/2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/1/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/16/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/11/2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/2/2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/26/2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
$600K25.62N/AN/A($0.02) per share-34.61
IRIDEX Corporation stock logo
IRIX
IRIDEX
$52.67M0.28N/AN/A($0.06) per share-14.27
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M0.95$7.33 per share0.02$1.05 per share0.14
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$7.68M0.59N/AN/A$9.41 per share0.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
-$25.08M-$1.53N/AN/AN/AN/A-661.85%-73.35%N/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$4.44M-$0.19N/AN/AN/A-6.23%N/A-11.16%8/18/2026 (Estimated)
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/AN/A-82.31%-51.47%N/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$33.25M-$68.40N/AN/AN/A-435.71%-364.17%-97.43%N/A

Latest XAIR, ADGM, TMDIF, and IRIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2026Q2 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.01N/AN/AN/A$13.59 millionN/A
8/13/2026Q1 2027
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$10.80-$11.00-$0.20-$11.00$1.93 million$1.77 million
8/11/2026Q2 2026
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
-$0.27-$0.30-$0.03-$0.30N/AN/A
6/26/2026Q4 2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$11.3334-$15.40-$4.0666-$15.40$2.30 million$1.91 million
5/19/2026Q1 2026
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.07-$0.03+$0.04-$0.03$11.91 million$11.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
4.00
1.41
1.66
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/A
1.92
1.19
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.48
3.80
3.59

Institutional Ownership

CompanyInstitutional Ownership
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
48.08%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.03%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
7.81%
IRIDEX Corporation stock logo
IRIX
IRIDEX
8.60%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.02%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
9.99%
CompanyEmployeesShares OutstandingFree FloatOptionable
Adagio Medical Holdings, Inc. stock logo
ADGM
Adagio Medical
8722.21 million20.48 millionN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
12017.41 million15.91 millionOptionable
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
70721,000649,000Optionable

Recent News About These Companies

Beyond Air, Inc. Q1 2027 Earnings Call Summary
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-inc-q1-2027-210809536.html
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
August 14 at 1:52 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-xair-q1-2027-035834380.html
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ...
August 13 at 8:51 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-inc-xair-q1-230916103.html
Beyond Air Reports $1.8 Million Q2 Revenue, Reaffirms 2026 and 2027 Guidance as FDA Reviews Second-Generation LungFit PH System
August 13 at 7:31 AM  |  quiverquant.comQ
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
August 13 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344347/0/en/beyond-air-reports-financial-results-for-the-quarter-ended-june-30-2026-and-provides-corporate-update.html
Beyond Air (XAIR) Projected to Post Earnings on Thursday
August 12 at 1:26 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30955317
Beyond Air Regains Nasdaq Compliance After Reverse Stock Split
August 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/beyond-air-regains-nasdaq-compliance-after-reverse-stock-split?utm_source=marketbeat.com&utm_medium=referral
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
August 4, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/beyond-air-schedules-conference-call-to-discuss-financial-results-for-the-quarter-ended-june-30-2026-1036405717
Daniel Moorhead Purchases 4,340 Shares of Beyond Air (NASDAQ:XAIR) Stock
August 1, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xair-insider-buying-and-selling-2026-08-01/
Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
July 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/30/3335916/0/en/beyond-air-announces-up-to-30-1-million-private-placement-offering-priced-at-the-market-under-nasdaq-rules.html
Beyond Air Implements Reverse Stock Split to Maintain Listing
July 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/beyond-air-implements-reverse-stock-split-to-maintain-listing?utm_source=marketbeat.com&utm_medium=referral
Beyond Air (XAIR) Q4 2026 Earnings Call Transcript
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/beyond-air-xair-q4-2026-003158976.html?fr=sycsrp_catchall
Beyond Air Inc (XAIR) Q4 2026 Earnings Call Highlights: Revenue Surge and Path to Profitability
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/beyond-air-inc-xair-q4-190022679.html
Beyond Air, Inc. (XAIR) Q4 2026 Earnings Call Transcript
June 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4918095-beyond-air-inc-xair-q4-2026-earnings-call-transcript
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
June 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/26/3318137/0/en/beyond-air-reports-fourth-quarter-and-full-year-2026-financial-results-and-provides-corporate-update.html
Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315599/0/en/beyond-air-schedules-fiscal-year-end-2026-financial-results-conference-call-and-webcast.html
Beyond Air, Inc. Schedules Special Meeting of Stockholders to Vote on Reverse Stock Split to Avoid Nasdaq Delisting
June 10, 2026  |  quiverquant.comQ
Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting
June 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/10/3309617/0/en/beyond-air-inc-urges-stockholders-to-vote-for-all-proposals-ahead-of-the-upcoming-special-meeting.html
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing
June 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/01/3304330/0/en/beyond-air-receives-nasdaq-hearing-panel-decision-granting-continued-listing.html
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
April 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/20/3276917/0/en/beyond-cancer-reports-updated-survival-and-safety-data-from-phase-1-uno-trial-presented-at-aacr-2026.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Adagio Medical stock logo

Adagio Medical NASDAQ:ADGM

$0.69 +0.00 (+0.32%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$0.68 -0.01 (-1.47%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.86 +0.03 (+3.87%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$0.86 0.00 (-0.12%)
As of 08/14/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.15 +0.01 (+4.49%)
As of 08/13/2026

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$6.32 -0.60 (-8.67%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$6.32 0.00 (0.00%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas